PRODUCT FILTER
Categories
Type
Type

Spirastad 3 M.I.U
Rx

Spirastad 3 M.I.U contains spiramycin is considered as a second-line drug for treatment of infectious conditions in respiratory, cutaneous and genital tracts caused by sensitive organisms.

Pack size Box of 10 tablets.
Shelf-life 24 months
Composition Spiramycin
Dosage forms and strengths Film-coated tablet: 3,000,000 IU (3 million IU)
Product code :

PRESCRIBING INFORMATION

Indications:

Infectious conditions in respiratory, cutaneous and genital tracts caused by sensitive organisms.

Prophylaxis of meningitis caused by Meningococci in patients with contraindication to rifampicin.

Prevention of congenital toxoplasmosis during pregnancy.

Chemoprophylaxis of recurrent acute rheumatic arthritis in patients allergic to penicillins.

Dosage:

Treatment of infectious conditions in respiratory, cutaneous and genital tracts; Chemoprophylaxis of recurrent acute rheumatic arthritis in patients allergic to penicillins:

  • Adults: 5 million – 3 million IU daily, in 2 or 3 divided doses. Doses up to 15 million units have been given daily in divided doses for severe infections.
  • Children ≥ 30 kg: 150 thousand IU/kg daily, in 3 divided doses. Use other preparation for children < 30 kg.

Prophylaxis of meningitis due to Meningococci:

  • Adults: 3 million IU every 12 hours for 5 days.
  • Children ≥ 20 kg: 75 thousand IU/kg every 12 hours for 5 days. Use other preparation for children < 20 kg.

Prevention of congenital toxoplasmosis during pregnancy: 9 million IU daily in divided doses for 3 weeks, repeated 2-weekly intervals

Usage:

Spirastad 3 M.I.U is administered orally. Because food in the stomach reduces the bioavailability of spiramycin, the dose should be administered at least 2 hours before or 3 hours after a meal.

Patients with known hypersensitivity to spiramycin, erythromycin or to any ingredient in the formulation.

Common: Nausea, vomiting, diarrhea, indigestion; vertigo, headache.

Uncommon: Fatigue, epistaxis, sweating, heaviness in the chest; acute colitis; exanthema, urticarial.

Spirastad 3 M.I.U must be discontinued if at the start of treatment, patients experience generalized erythema and pustules accompanied by fever. Any further administration of spiramycin alone or in combination is contraindicated.

Spirastad 3 M.I.U should be used cautiously in patients with hepatic dysfunction, heart disease, arrhythmia (including people tend to prolong the QT interval); pregnant women.

Mothers should discontinue breast feeding during spiramycin administration.

Patients should be aware of how they react to drug before driving or operating machinery.